However, when we similarly recapitulated PD-1+ B-ALL disease in nu/nu mice, which lack T cells but possess NK cells, PD-1 targeting efficiently reduced the disease burden (Figure 4E,F). This evidence concerns the gene PDCD1 and precursor B-cell acute lymphoblastic leukemia.